July 2021 Generic Product News

Pharmacy Times, July 2021, Volume 87, Issue 7

This month's featured products include an ophthalmic solution, darifenacin ER tablets, and more.

Dorzolamide Hydrochloride, Timolol Maleate Ophthalmic Solution, 2% and 0.5%

Marketed by Alembic Pharmaceuticals

Compare to: Cosopt

FDA officials recently approved Alembic’s generic dorzolamide hydrochloride (2%) and timolol maleate (0.5%) ophthalmic solution. It is indicated for the reduction of elevated intraocular pressure in patients with ocular hypertension and open-angle glaucoma who are insufficiently responsive to β-blockers. Common adverse effects include cloudy or double vision, sensitivity to light, temporary blurred vision, and watery eyes. The ophthalmic solution had a market value of approximately $80 million for the 12 months ending in December 2020, according to data from IQVIA.

For more information: alembicpharmaceuticals.com

Darifenacin ER Tablets

Marketed by Xiromed

Compare to: Enablex

Patients with an overactive bladder have a new option to manage symptoms, including frequency, urgency, and urinary incontinence, with the recent introduction of Xiromed’s generic darifenacin extended-release tablets. The drug relaxes muscles in the bladder and improves patients’ ability to control their urination. Common adverse effects include blurred vision, constipation, dizziness, dry mouth, nausea, and weakness. According to a company news release, Enablex and its generics had a market value of $11.2 million for the 12-month period ending in February 2021.

For more information: xiromed.com

Nystatin and Triamcinolone Acetonide Cream

Manufactured by Alembic Pharmaceuticals

Compare to: Taro Pharmaceuticals Nystatin and Triamcinolone Acetonide Cream

Alembic is launching nystatin and triamcinolone acetonide cream in 100,00 units/gram and 1 mg/gram dosages for the treatment of cutaneous candidiasis. Cutaneous candidiasis typically occurs in areas exposed to moisture for long periods of time, and symptoms can include a red rash. Nystatin works to stop the growth of fungi, whereas triamcinolone acetonide works by reducing itching, redness, and swelling. Common adverse effects include burning, drying, and skin irritation, although these effects should lessen in a few days as the skin adjusts to the medication.

For more information: alembicpharmaceuticals.com

Erythromycin Tablets

Manufactured by Teva Pharmaceuticals

Compare to: Erythrocin

Teva’s generic erythromycin tablets soon will be available in dosage strengths of 250 and 500 mg for managing a wide array of bacterial infections and preventing initial or recurrent attacks of rheumatic fever in patients allergic to penicillin. As a macrolide antibiotic, erythromycin works by stopping the growth of bacteria. Adverse effects include diarrhea, loss of appetite, nausea, stomach cramping or pain, and vomiting. Erythromycin oral tablets had a market value of more than $49 million as of January 2021, according to data from IQVIA.

For more information: tevapharm.com